BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/3/2025 8:25:32 AM | Browse: 4 | Download: 12
 |
Received |
|
2024-11-25 13:49 |
 |
Peer-Review Started |
|
2024-11-25 13:50 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-02-13 03:40 |
 |
Revised |
|
2025-02-26 16:53 |
 |
Second Decision |
|
2025-03-17 02:38 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-03-17 09:12 |
 |
Articles in Press |
|
2025-03-17 09:12 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2025-05-28 01:40 |
 |
Publish the Manuscript Online |
|
2025-06-03 08:25 |
ISSN |
2150-5349 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Editorial |
Article Title |
Nalbuphine vs sufentanil as effective analgesics for postoperative pain management in gastric cancer resection
|
Manuscript Source |
Invited Manuscript |
All Author List |
Wei-Xiang Wang, Fu-Lin Dang, Ting-Ting Li and Yue Yu |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Natural Science Foundation of China |
No. 82404612 |
|
Corresponding Author |
Yue Yu, Associate Professor, PhD, Department of Pharmacy and Fujian Center for New Drug Safety Evaluation, Fujian Medical University, No. 1 Xuefu North Road, New District, Fuzhou 350013, Fujian Province, China. yyu@fjmu.edu.cn |
Key Words |
Nalbuphine; Sufentanil; Postoperative pain management; Radical gastrectomy; Multimodal analgesia; Enhanced recovery after surgery |
Core Tip |
Enhanced recovery after surgery (ERAS) protocols emphasize optimal pain management while minimizing opioid-related complications. This editorial highlights the comparative efficacy and safety profile of nalbuphine vs sufentanil in postoperative pain management following radical gastrectomy. The study demonstrates nalbuphine's advantages in terms of pain control, reduced inflammatory response, and fewer adverse events. Particularly noteworthy is its potential role in multimodal analgesia within ERAS protocols, offering a promising alternative for optimizing postoperative recovery while minimizing opioid-related complications. |
Publish Date |
2025-06-03 08:25 |
Citation |
<p>Wang WX, Dang FL, Li TT, Yu Y. Nalbuphine vs sufentanil as effective analgesics for postoperative pain management in gastric cancer resection. <i>World J Gastrointest Pharmacol Ther</i> 2025; 16(2): 103232</p> |
URL |
https://www.wjgnet.com/2150-5349/full/v16/i2/103232.htm |
DOI |
https://dx.doi.org/10.4292/wjgpt.v16.i2.103232 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345